FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| SCA Pharmaceuticals, LLC | 080545245 | Fentanyl Citrate | .01 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 080545245 | Fentanyl Citrate | .01 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 080545245 | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; .625 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 080545245 | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1.25 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 080545245 | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1.25 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 080545245 | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1.25 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 080545245 | Fentanyl Citrate; Bupivacaine Hydrochloride | .005 mg/1 mL; 4 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 037559301 | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1.25 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 037559301 | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1.25 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 037559301 | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1.25 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 080545245 | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 080545245 | Fentanyl Citrate; Ropivacaine Hydrochloride | .002 mg/1 mL; 2 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 037559301 | Fentanyl Citrate; Ropivacaine Hydrochloride | .002 mg/1 mL; 2 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 080545245 | Fentanyl Citrate; Ropivacaine Hydrochloride | .002 mg/1 mL; 1 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 080545245 | Hydromorphone Hydrochloride | .2 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 080545245 | Hydromorphone Hydrochloride | .2 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 080545245 | Hydromorphone Hydrochloride | 1 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 080545245 | Hydromorphone Hydrochloride | 1 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 037559301 | Hydromorphone Hydrochloride | .2 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 037559301 | Hydromorphone Hydrochloride | .2 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 037559301 | Hydromorphone Hydrochloride | .2 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 037559301 | Hydromorphone Hydrochloride | 1 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 080545245 | Ketamine Hydrochloride | 10 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 037559301 | Ketamine Hydrochloride | 10 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 037559301 | Ketamine Hydrochloride | 10 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 080545245 | Ketamine Hydrochloride | 50 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 080545245 | Labetalol Hydrochloride | 5 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 037559301 | Lidocaine Hydrochloride | 20 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 080545245 | Lidocaine Hydrochloride | 10 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 080545245 | Lidocaine Hydrochloride | 20 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 037559301 | Methadone Hydrochloride | 10 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 080545245 | Methadone Hydrochloride | 10 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 080545245 | Norepinephrine Bitartrate | .064 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 080545245 | Norepinephrine Bitartrate | .032 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 080545245 | Oxytocin | 30 U/500 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SKNV | 080105003 | 72934-4598 | 72934-4598-8 | Betamethasone Dipropionate; Minoxidil; Niacinamide; Pentoxifylline | .05 g/100 mL; 5 g/100 mL; 2 g/100 mL; .5 g/100 mL | 2025-2 | valid | 2026-08-12 | |
| SKNV | 080105003 | 72934-1530 | 72934-1530-2 | Brimonidine Tartrate | .25 g/100 g | 2025-2 | valid | 2026-08-12 | |
| SKNV | 080105003 | 72934-7558 | 72934-7558-6 | Salicylic Acid; Ciclopirox Olamine; Clobetasol Propionate | 3 g/100 mL; .77 g/100 mL; .05 g/100 mL | 2025-2 | valid | 2026-08-12 | |
| SKNV | 080105003 | 72934-7556 | 72934-7556-6 | Salicylic Acid; Ketoconazole | 2 g/100 mL; 2 g/100 mL | 2025-2 | valid | 2026-08-12 | |
| SKNV | 080105003 | 72934-1543 | 72934-1543-2 | Salicylic Acid; Lidocaine | 40 g/100 g; 5 g/100 g | 2025-2 | valid | 2026-08-12 | |
| SKNV | 080105003 | 72934-8552 | 72934-8552-7 | Salicylic Acid; Sulfacetamide Sodium | 2 g/100 mL; 8 g/100 mL | 2025-2 | valid | 2026-08-12 | |
| SKNV | 080105003 | 72934-8552 | 72934-8552-6 | Salicylic Acid; Sulfacetamide Sodium | 2 g/100 mL; 8 g/100 mL | 2025-2 | valid | 2026-08-12 | |
| SKNV | 080105003 | 72934-8553 | 72934-8553-6 | Salicylic Acid; Sulfacetamide Sodium | 5 g/100 mL; 10 g/100 mL | 2025-2 | valid | 2026-08-12 | |
| SKNV | 080105003 | 72934-1591 | 72934-1591-2 | Spironolactone; Benzoyl Peroxide; Clindamycin Phosphate; Niacinamide; Tretinoin | 4 g/100 g; 10 g/100 g; 2 g/100 g; 4 g/100 g; .05 g/100 g | 2025-2 | valid | 2026-08-12 | |
| SKNV | 080105003 | 72934-2590 | 72934-2590-2 | Spironolactone; Dapsone; Niacinamide | 5 g/100 g; 8.5 g/100 g; 2 g/100 g | 2025-2 | valid | 2026-08-12 | |
| SKNV | 080105003 | 72934-2554 | 72934-2554-2 | Sulfacetamide Sodium; Niacinamide | 10 g/100 g; 4 g/100 g | 2025-2 | valid | 2026-08-12 | |
| SKNV | 080105003 | 72934-3570 | 72934-3570-2 | Sulfacetamide Sodium; Niacinamide | 15 g/100 g; 4 g/100 g | 2025-2 | valid | 2026-08-12 | |
| SKNV | 080105003 | 72934-2540 | 72934-2540-2 | Tacrolimus | .1 g/100 g | 2025-2 | valid | 2026-08-12 | |
| SKNV | 080105003 | 72934-4603 | 72934-4603-8 | Tacrolimus | .1 g/100 mL | 2025-2 | valid | 2026-08-12 | |
| SKNV | 080105003 | 72934-5501 | 72934-5501-0 | Tacrolimus; Niacinamide | .1 g/100 g; 4 g/100 g | 2025-2 | valid | 2026-08-12 |